Discovery of Antinociceptive α9α10 Nicotinic Acetylcholine Receptor Antagonists by Stable Receptor Expression
- 13 October 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 19 (11) , 2291-2303
Abstract
Chronic neuropathic pain is an increasingly prevalent societal issue that responds poorly to existing therapeutic strategies. The α9α10 nicotinic acetylcholine receptor (nAChR) has emerged as a potential target to treat neuropathic pain. However, challenges in expressing functional α9α10 nAChRs in mammalian cell lines have slowed the discovery of α9α10 ligands and studies into the relationship between α9α10 nAChRs and neuropathic pain. Here, we develop a cell line in the HEK293 background that stably expresses functional α9α10 nAChRs. By also developing cell lines expressing only α9 and α10 subunits, we identify distinct receptor pharmacology between homomeric α9 or α10 and heteromeric α9α10 nAChRs. Moreover, we demonstrate that incubation with nAChR ligands differentially regulates the expression of α9- or α10-containing nAChRs, suggesting a possible mechanism by which ligands may modify receptor composition and trafficking in α9- and α10-expressing cells. We then apply our α9α10 cell line in a screen of FDA-approved and investigational drugs to identify α9α10 ligands that provide new tools to probe α9α10 nAChR function. We demonstrate that one compound from this screen, diphenidol, possesses antinociceptive activity in a murine model of neuropathic pain. These results expand our understanding of α9α10 receptor pharmacology and provide new starting points for developing efficacious neuropathic pain treatments.Keywords
Funding Information
- National Institute on Drug Abuse (R00DA041500)
- National Institute of General Medical Sciences (R35GM147005)
- National Heart and Lung Institute (R35HL140031)
This publication has 38 references indexed in Scilit:
- Structure of the Native Muscle-type Nicotinic Receptor and Inhibition by Snake Venom ToxinsNeuron, 2020
- Molecular, Cellular and Circuit Basis of Cholinergic Modulation of PainNeuroscience, 2018
- Nicotinic acetylcholine receptors in neuropathic and inflammatory painFEBS Letters, 2017
- Gabapentin for chronic neuropathic pain in adultsCochrane Database of Systematic Reviews, 2017
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisThe Lancet Neurology, 2015
- The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesicEuropean Journal of Pharmacology, 2011
- Immunohistochemical detection of nicotinic acetylcholine receptor subunits α9 and α10 in rat lung isografts and allograftsLife Sciences, 2007
- Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult ratAutonomic Neuroscience, 2004
- Coexpression of α9 and α10 nicotinic acetylcholine receptors in rat dorsal root ganglion neuronsNeuroscience, 2002
- Molecular Cloning and Mapping of the Human Nicotinic Acetylcholine Receptor α10 (CHRNA10)Genomics, 2001